Epitalon

Last updated
Epitalon
Epitalon.png
Names
IUPAC name
(4S)-4-[[(2S)-2-aminopropanoyl]amino]-5-[[(2S)-3-carboxy-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Other names
  • Epithalon
  • Epithalone
  • Ala-Glu-Asp-Gly
  • L-Alanyl-L-glutamyl-L-aspartyl-glycine
  • UNII-O65P17785G
Identifiers
3D model (JSmol)
ChemSpider
MeSH C421253
PubChem CID
UNII
  • InChI=1S/C14H22N4O9/c1-6(15)12(25)17-7(2-3-9(19)20)14(27)18-8(4-10(21)22)13(26)16-5-11(23)24/h6-8H,2-5,15H2,1H3,(H,16,26)(H,17,25)(H,18,27)(H,19,20)(H,21,22)(H,23,24)/t6-,7-,8-/m0/s1
    Key: HGHOBRRUMWJWCU-FXQIFTODSA-N
  • CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NCC(=O)O)N
Properties
C14H22N4O9
Molar mass 390.349
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Epitalon is a synthetic peptide, telomerase activator, and putative anti-aging compound, [1] [2] which was identified as the putative active component of a bovine pineal gland extract known as epithalamin. [3]

Contents

Most studies on epitalon and epithalamin have been conducted by the St. Petersburg Institute of Bioregulation and Gerontology, primarily overseen by Vladimir Khavinson, in Russia. [2] [4] [5] [6] [7]

Chemistry

Epitalon is a tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly and the molecular formula C14H22N4O9. [8]

Biological effects

Studies in vitro

Epitalon appears to induce telomere elongation via increased telomerase activity in human somatic cells in vitro , based on a study in human fibroblast cell cultures. [1]

Elongation of telomeres by epitalon was sufficient to surpass the Hayflick limit in a cell culture of human fetal fibroblast cells, extending their proliferative potential from termination at the 34th passage in the control cell population to beyond the 44th passage in the treated cell population, while increasing the lengths of their telomeres to levels comparable to those of cells in the original culture. [9]

Epitalon induces decondensation of heterochromatin near the centromeres in cultured lymphocytes originating from samples taken from humans of ages 76 to 80 years. [10]

Epitalon appears to inhibit the synthesis of the MMP9 protein in vitro in aging skin fibroblasts. [11]

Animal studies in vivo

An in vivo study in aging mice found that epitalon treatment significantly reduced the incidence of chromosomal aberrations, both for wild-type mice and for mice characterized by an accelerated aging phenotype, which is consistent with increases in telomere length. [12]

Another study in aging rats found that epitalon increased the activities of the antioxidant enzymes superoxide dismutase, glutathione peroxidase, and glutathione-S-transferase. [3]

Epitalon reduced the number of spontaneous tumors and the number of metastases in mice that did develop spontaneous tumors in an experiment on one-year-old female C3H/He mice, and is speculated to have oncostatic and anti-metastatic properties. [13]

In a study of chickens subjected to neonatal hypophysectomy and subsequent maturation, epitalon promoted the recovery of the morphological structures of the thymus, [14] as well as the structure and function of the thyroid gland. [15]

Epitalon appears to increase the proliferation of lymphocytes in the thymus, putatively increasing production of interferon gamma by T-cells. [16]

Another study in aging rats demonstrated extension of life span for rats subjected to constant illumination or to a natural light regimen typical of northern regions. [8]

Human clinical studies

In human clinical studies, epitalon and epithalamin both significantly increased telomere lengths in the blood cells of patients of ages 60-65 and 75-80, and their efficacy was comparable to one another. [17] [18]

Epitalon and epithalamin appear to restore melatonin secretion by the pineal gland [3] in both aged monkeys and humans. [19]

A human clinical trial conducted on a sample of retinitis pigmentosa patients found that epitalon produced a positive clinical effect in 90% of cases in the treated group. [20]

In another human clinical trial conducted on a sample of pulmonary tuberculosis patients, epitalon did not appear to correct pre-existing structural aberrations of chromosomes associated with telomere degradation, but did appear to exert a protective effect against the future development of additional chromosomal aberrations. [21]

A human prospective cohort study conducted on a sample of 266 people over age 60 demonstrated that treatment with epithalamin, the pineal gland extract upon which epitalon is based, produced a 1.6–1.8-fold reduction in mortality during the following 6 years, a 2.5-fold reduction in mortality when combined with thymalin, and a 4.1-fold reduction in mortality when combined with thymalin and administered annually instead of only once at study onset. [22] [23]

Another prospective cohort study on a sample of 79 coronary patients spanning in excess of 12 years found improved metrics of physical endurance, circadian rhythm, and carbohydrate and lipid metabolism in the treated group relative to the control group following 3 years of biannual epithalamin treatments, as well as a 50% lower rate of cardiovascular mortality, a 50% lower rate of cardiovascular failure and serious respiratory disease, and a 28% lower rate of overall mortality. [24] [25]

See also

Related Research Articles

<span class="mw-page-title-main">Pinealocyte</span> Main cells contained in the pineal gland

Pinealocytes are the main cells contained in the pineal gland, located behind the third ventricle and between the two hemispheres of the brain. The primary function of the pinealocytes is the secretion of the hormone melatonin, important in the regulation of circadian rhythms. In humans, the suprachiasmatic nucleus of the hypothalamus communicates the message of darkness to the pinealocytes, and as a result, controls the day and night cycle. It has been suggested that pinealocytes are derived from photoreceptor cells. Research has also shown the decline in the number of pinealocytes by way of apoptosis as the age of the organism increases. There are two different types of pinealocytes, type I and type II, which have been classified based on certain properties including shape, presence or absence of infolding of the nuclear envelope, and composition of the cytoplasm.

Calorie restriction mimetics (CRM), also known as energy restriction mimetics, are a hypothetical class of dietary supplements or drug candidates that would, in principle, mimic the substantial anti-aging effects that calorie restriction (CR) has on many laboratory animals and humans. CR is defined as a reduction in calorie intake of 20% to 50% without incurring malnutrition or a reduction in essential nutrients. An effective CRM would alter the key metabolic pathways involved in the effects of CR itself, leading to preserved youthful health and longer lifespan without the need to reduce food intake. The term was coined by Lane, Ingram, Roth of the National Institute on Aging in a seminal 1998 paper in the Journal of Anti-Aging Medicine, the forerunner of Rejuvenation Research. A number of genes and pathways have been shown to be involved with the actions of CR in model organisms and these represent attractive targets for drug discovery and for developing CRM. However, no effective CRM have been identified to date.

<span class="mw-page-title-main">Hayflick limit</span> Limit to divisions of a normal human cell

The Hayflick limit, or Hayflick phenomenon, is the number of times a normal somatic, differentiated human cell population will divide before cell division stops. However, this limit does not apply to stem cells.

Delta-sleep-inducing peptide (DSIP) is a neuropeptide that when infused into the mesodiencephalic ventricle of recipient rabbits induces spindle and delta EEG activity and reduced motor activities.

<span class="mw-page-title-main">Adrenomedullin</span>

Adrenomedullin is a vasodilator peptide hormone of uncertain significance in human health and disease. It was initially isolated in 1993 from a pheochromocytoma, a tumor of the adrenal medulla: hence the name.

<span class="mw-page-title-main">Mannan-binding lectin</span> Mammalian protein found in Homo sapiens

Mannose-binding lectin (MBL), also called mannan-binding lectin or mannan-binding protein (MBP), is a lectin that is instrumental in innate immunity as an opsonin and via the lectin pathway.

<span class="mw-page-title-main">CXCL5</span> Mammalian protein found in Homo sapiens

C-X-C motif chemokine 5 is a protein that in humans is encoded by the CXCL5 gene.

<span class="mw-page-title-main">Neurokinin B</span> Chemical compound

Neurokinin B (NKB) belongs in the family of tachykinin peptides. Neurokinin B is implicated in a variety of human functions and pathways such as the secretion of gonadotropin-releasing hormone. Additionally, NKB is associated with pregnancy in females and maturation in young adults. Reproductive function is highly dependent on levels of both neurokinin B and also the G-protein coupled receptor ligand kisspeptin. The first NKB studies done attempted to resolve why high levels of the peptide may be implicated in pre-eclampsia during pregnancy. NKB, kisspeptin, and dynorphin together are found in the arcuate nucleus (ARC) known as the KNDy subpopulation. This subpopulation is targeted by many steroid hormones and works to form a network that feeds back to GnRH pulse generator.

<span class="mw-page-title-main">Prolyl endopeptidase</span>

Prolyl endopeptidase (PE) also known as prolyl oligopeptidase or post-proline cleaving enzyme is an enzyme that in humans is encoded by the PREP gene.

<span class="mw-page-title-main">Acetylserotonin O-methyltransferase</span> Mammalian protein found in humans

N-Acetylserotonin O-methyltransferase, also known as ASMT, is an enzyme which catalyzes the final reaction in melatonin biosynthesis: converting Normelatonin to melatonin. This reaction is embedded in the more general tryptophan metabolism pathway. The enzyme also catalyzes a second reaction in tryptophan metabolism: the conversion of 5-hydroxy-indoleacetate to 5-methoxy-indoleacetate. The other enzyme which catalyzes this reaction is n-acetylserotonin-o-methyltransferase-like-protein.

<span class="mw-page-title-main">INHA</span> Protein and coding gene in humans

Inhibin, alpha, also known as INHA, is a protein which in humans is encoded by the INHA gene.

Flow-FISH is a cytogenetic technique to quantify the copy number of RNA or specific repetitive elements in genomic DNA of whole cell populations via the combination of flow cytometry with cytogenetic fluorescent in situ hybridization staining protocols.

<span class="mw-page-title-main">CIDEA</span> Protein-coding gene in the species Homo sapiens

Cell death activator CIDE-A is a protein that in humans is encoded by the CIDEA gene. Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids.

Melatonin receptor 1C, also known as MTNR1C, is a protein that is encoded by the Mtnr1c gene. This receptor has been identified in fish, amphibia, and birds, but not in humans.

<span class="mw-page-title-main">Vladimir Khavinson</span>

Vladimir Khavinson - is a Professor, Treasurer of the European region of the International Association of Gerontology and Geriatrics; Main gerontologist of the Health Committee of the Government of Saint Petersburg, Russia; Director of the Saint Petersburg Institute of Bioregulation and Gerontology; Vice-president of Gerontological Society of the Russian Academy of Sciences; Head of the Chair of Gerontology and Geriatrics of the North-Western State Medical University, St-Petersburg; Colonel of medical service, retired.

<span class="mw-page-title-main">Apoptosis-inducing factor, mitochondria-associated 3</span> Protein-coding gene in the species Homo sapiens

Apoptosis-inducing factor, mitochondria-associated 3 is a protein that in humans is encoded by the AIFM3 gene.

The disposable soma theory of aging states that organisms age due to an evolutionary trade-off between growth, reproduction, and DNA repair maintenance. Formulated by Thomas Kirkwood, the disposable soma theory explains that an organism only has a limited amount of resources that it can allocate to its various cellular processes. Therefore, a greater investment in growth and reproduction would result in reduced investment in DNA repair maintenance, leading to increased cellular damage, shortened telomeres, accumulation of mutations, compromised stem cells, and ultimately, senescence. Although many models, both animal and human, have appeared to support this theory, parts of it are still controversial. Specifically, while the evolutionary trade-off between growth and aging has been well established, the relationship between reproduction and aging is still without scientific consensus, and the cellular mechanisms largely undiscovered.

<span class="mw-page-title-main">Glufimet</span> Chemical compound

Glufimet, also known as dimethyl 3-phenylglutamate hydrochloride, is a derivative of glutamic acid (glutamate) which was developed in Russia and is related to the γ-aminobutyric acid (GABA) derivative phenibut (3-phenyl-GABA). It contains phenibut and glycine fragments in its chemical structure, has been described as a "GABA precursor", and is said to modulate the GABA and nitric oxide (NO) systems and to have antioxidant activity. It has been suggested that metabotropic glutamate receptors may also play a role in the mechanism of action of glufimet. Stress-protective effects have been described for glufimet in animals.

Benjamin Weiss is an American neuropharmacologist, Emeritus Professor of Pharmacology and Physiology at Drexel University College of Medicine. He is best known for his work with cyclic nucleotide phosphodiesterases. He was the first to propose, based on his experimental work, that selective inhibition of phosphodiesterases which are expressed differentially in all tissues, could be used as a target for drug development. His work is the basis for many marketed and developmental human drugs that selectively inhibit cyclic nucleotide phosphodiesterases.

References

  1. 1 2 Khavinson, VKh; Bondarev, IE; Butyugov, AA (2003). "Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells". Bull Exp Biol Med. 135 (6): 590–592. doi:10.1023/a:1025493705728. PMID   12937682. S2CID   7762518.
  2. 1 2 Khavinson, VKh; Kuznik, BI; Tarnovskaia, SI; Lin'kova, NS (2014). "Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data". Adv Gerontol. 27 (3): 399–406. PMID   25826983.
  3. 1 2 3 Kozina, LS; Arutjunyan, AV; Khavinson, VKh (2007). "Antioxidant properties of geroprotective peptides of the pineal gland". Arch Gerontol Geriatr. 44: 213–216. doi:10.1016/j.archger.2007.01.029. PMID   17317455.
  4. Khavinson, VKh; Lin'kova, NS (2012). "Morphofunctional and molecular bases of pineal gland aging". Fizol Cheloveka. 38 (1): 119–127. PMID   22567846.
  5. Anisimov, VN; Khavinson, VKh (2009). "The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives". Vopr Onkol. 55 (3): 291–304. PMID   19670728.
  6. Khavinson, VKh (2002). "Peptides and aging". Neuro Endocrinol Lett. 23 (3): 11–144. PMID   12374906.
  7. "Top Management". eng.gerontology.ru. St. Petersburg Institute of Bioregulation and Gerontology. Archived from the original on 2018-01-09. Retrieved 2018-01-08.
  8. 1 2 Vinogradova, IA; Bukalev, AV; Zabezhinski, MA; Semenchenko, AV; Khavinson, VKh; Anisimov, VN (2007). "Effect of Ala-Glu-Asp-Gly peptide on life span and development of spontaneous tumors in female rats exposed to different illumination regimes". Bull Exp Biol Med. 144 (6): 825–830. doi:10.1007/s10517-007-0441-z. PMID   18856211. S2CID   930323.
  9. Khavinson, VKh; Bondarev, IE; Butyugov, AA; Smirnova, TD (2004). "Peptide promotes overcoming of the division limit in human somatic cell". Bull Exp Biol Med. 137 (5): 503–506. doi:10.1007/s10517-016-3370-x. PMID   15455129. S2CID   13941652.
  10. Khavinson, VKh; Lezhava, TA; Monaselidze, JR; Jokhadze, TA; Dvalishvili, NA; Bablishvili, NK; Trofimova, SV (2003). "Peptide Epitalon activates chromatin at the old age". Neuro Endocrinol Lett. 24 (5): 329–333. PMID   14647006.
  11. Lin'kova, NS; Drobintseva, AO; Orlova, OA; Kuznetsova, EP; Polyakova, VO; Kvetnoy, IM; Khavinson, VKh (2016). "Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro". Bull Exp Biol Med. 161 (1): 175–178. doi:10.1007/s10517-016-3370-x. PMID   27259496. S2CID   13941652.
  12. Rosenfeld, SV; Togo, EF; Mikheev, VS; Popovich, IG; Khavinson, VKh; Anisimov, VN (2002). "Effect of epithalon on the incidence of chromosome aberrations in senescence-accelerated mice". Bull Exp Biol Med. 133 (3): 274–276. doi:10.1023/a:1015899003974. PMID   12360351. S2CID   26550927.
  13. Kossoy, G; Anisimov, VN; Ben-Hur, H; Kossoy, N; Zusman, I (2006). "Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice". In Vivo. 20 (2): 253–257. PMID   16634527.
  14. Pateyk, AV; Baranchugova, LM; Rusaeva, NS; Obydenko, VI; Kuznik, BI (2013). "Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds". Bull Exp Biol Med. 154 (5): 681–685. doi:10.1007/s10517-013-2029-0. PMID   23658898. S2CID   30171446.
  15. Kuznik, BI; Pateiuk, AV; Rusaeva, NS; Baranchugova, LM; Obydenko, VI (2010). "Effects of hypophyseal Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly synthetic peptides on immunity, hemostasis, morphology and functions of the thyroid gland in neonatally hypophysectomized chicken and one-year-old birds". Patol Fiziol Eksp Ter. 1 (1): 14–18. PMID   20731122.
  16. Lin'kova, NS; Kuznik, BI; Khavinson, VKh (2012). "Peptide Ala-Glu-Asp-Gly and interferon gamma: their role in immune response during aging". Adv Gerontol. 25 (3): 478–482. PMID   23289226.
  17. Khavinson, Vladimir (2015-07-03). "Peptides, Genome, Aging". khavinson.info. Prof. Vladimir Khavinson. p. 79. Archived from the original on 2018-01-09. Retrieved 2018-01-08.
  18. Khavinson, Vladimir (2015-07-03). "Peptides, Genome, Aging". slideshare.net. SlideShare. p. 79. Archived from the original on 2018-01-09. Retrieved 2018-01-08.
  19. Korkushko, OV; Lapin, BA; Goncharova, ND; Khavinson, VKh; Shatilo, VB; Vengerin, AA; Antoniuk-Shcheglova, IA; Magdich, LV (2007). "Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people". Adv Gerontol. 20 (1): 74–85. PMID   17969590.
  20. Khavinson, V; Razumovsky, M; Trofimova, S; Grigorian, R; Razumovskaya, A (2002). "Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa". Neuro Endocrinol Lett. 23 (4): 365–368. PMID   12195242.
  21. Dzhokhadze, TA; Buadze, TZh; Rubanov, KD; Kiriia, NA; Lezhava, TA (2013). "Genome instability in pulmonary tuberculosis before and after treatment". Georgian Med News. 224 (224): 77–81. PMID   24323970.
  22. Khavinson, VKh; Morozov, VG (2003). "Peptides of pineal gland and thymus prolong human life". Neuro Endocrinol Lett. 24 (3): 233–240. PMID   14523363.
  23. Khavinson, VKh; Morozov, VG (2002). "Geroprotective effect of thymalin and epithalamin". Adv Gerontol. 10: 74–84. PMID   12577695.
  24. Korkushko, O; Khavinson, VKh; Shatilo, VB; Antonyk-Sheglova, IA (2011). "Geroprotective effect of thymalin and epithalamin". Adv Gerontol. 10 (3): 74–84. doi:10.1007/s10517-011-1332-x. PMID   22451889. S2CID   22194443.
  25. Korkushko, OV; Khavinson, VKh; Shatilo, VB; Antonuk-Sheglova, IA (2006). "Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging". Bull Exp Biol Med. 142 (3): 356–359. doi:10.1007/s10517-006-0365-z. PMID   17426848. S2CID   31963683.